/Investor DB

Leaps by Bayer — Full Portfolio

53 tracked investments · listed companies and verified rows first

Azitraazitrainc.comNYSE: AZTROct 2020 · $17M

Azitra is a clinical-stage biopharmaceutical company developing genetically engineered bacteria and proteins for treating skin diseases through precision dermatology.

AI & Machine LearningBiotechHealthtechFarmington, US

Francisco D. Salva(President and Chief Executive Officer)inAzim Munivar(Executive Officer, Director, Promoter)

BoardStella Robertson(Director)inTravis Whitfill(Executive Officer, Director, Promoter)in

Co-investorsBios PartnersConnecticut InnovationsKdT Ventures

Dewpoint Therapeuticsdewpointx.comin𝕏Feb 2022✓ verified

Dewpoint Therapeutics develops condensate-modulating drugs by using an integrated platform that maps, measures, and modulates biomolecular condensates to identify druggable targets and disease mechanisms.

AI & Machine LearningBiotechDeep TechBoston, US

Richard Young, Ph.D.(Director)inAnthony Hyman, Ph.D.(Director)Tony Hyman(Scientific Co-founder)Rick Young(Scientific Co-founder)Elisabeth Leiderman(Executive Officer)inIsaac Klein, M.D., Ph.D.(Executive Officer)

Co-investorsARCH Venture PartnersEcoR1 CapitalGeneral CatalystSamsara BioCapital6 Dimensions CapitalInnovation Endeavors+6 more

Grobiogrobio.comin𝕏Nov 2021 · $25M✓ verified

GRObio (GRO Biosciences) develops protein therapeutics using non-standard amino acids (NSAAs) via its GRO platform, aiming to improve protein potency, stability, and function.

BiotechDeep TechHealthtechCambridge, US

Daniel J Mandell(Chief Executive Officer)Tracey Lodie(Executive Officer)inChristopher Gregg(Director)

BoardMing Fang(Director)Bruce Beutel(Director)Dan Becker(Director)

Co-investorsREDMILEAlumni VenturesDigitalis VenturesDreamers VCRising TideAccess Industries+3 more

Indapta Therapeuticsindapta.comMay 2025 · $50M✓ verified

Indapta Therapeutics develops an off-the-shelf, allogeneic FcRγ-deficient natural killer (g-NK) cell therapy derived from healthy donors to treat cancer and autoimmune diseases.

BiotechHealthtechHouston, US

Guy DiPierro(Chief Operating Officer & Co-Founder)inSungjin Kim(Scientific Founder)John Sunwoo(Scientific Founder)Mark W. Frohlich(Chief Executive Officer)Stefanie Mandl-Cashman(Acting Chief Scientific Officer)

BoardLori Hu(Director)in

Co-investorsRA CapitalVertex Ventures HC

SonoTherasonothera.comin𝕏Jun 2026✓ verified

SonoThera is developing a nonviral, non-invasive gene delivery technology that uses ultrasound and microbubbles (ultrasound-mediated delivery) to deliver genetic payloads to targeted sites in a redosable way.

BiotechDeep TechDigital HealthHealthtechSouth San Francisco, US

Kenneth Greenberg(Co-Founder, President & CEO)in

Co-investorsVida VenturesARCH Venture PartnersFoothill VenturesIllumina VenturesMedical Excellence CapitalVivo Capital+8 more

Soufflé Therapeuticssouffletx.comin✓ verified

Soufflé Therapeutics develops nucleic acid medicines that precisely target and deliver genetic therapeutics to specific cell types to treat disease.

AI & Machine LearningBiotechDeep TechWatertown, US

Victor Kotelianski(Founder)Daniel Anderson(Founder and Director)Robert Langer(Founder)Marino Zerial(Founder)Brad Pentelute(Founder)Amir Nashat, ScD(Founder, Director and CEO)

Co-investorsBessemer Venture PartnersSafar PartnersVida VenturesPolaris Partners

65LAB65lab.sgOct 2023

65LAB accelerates drug discovery and therapeutic company formation by connecting academic research institutions, life science investors, and Evotec to develop novel medicines into commercial entities.

BiotechDeep TechSingapore, SG

BoardSteve Courtney(Expert in Residence)

Co-investorsLightstone VenturesClavystBio

Accent Therapeuticsaccenttx.comin𝕏Series C · Jan 2024 · $75M

Accent Therapeutics is a biotechnology company focused on discovering and developing small molecule drugs to improve health outcomes for cancer patients.

BiotechHealthtechLongevity

Co-investorsAtlas VentureDroia VenturesEcoR1 CapitalGV (Google Ventures)The Column GroupAbbVie+3 more

Ada Healthada.comin𝕏Feb 2022

Ada offers intelligent health technology, including a medical library of doctor-created, research-based information about conditions and symptoms to help people make informed health decisions.

AI & Machine LearningDigital HealthHealthtech

Claire Novorol(Founder)Daniel Nathrath(Founder)Martin Hirsch(Founder)

Co-investorsRed River WestSamsung Catalyst FundUrania Ventures10x FoundersBertelsmann InvestmentsMutschler Ventures+1 more

Affini-Taffinittx.comin𝕏Mar 2022 · $175M

Affini-T Therapeutics develops TCR-based immunotherapies aimed at treating solid tumors, using two complementary therapeutic modalities.

BiotechHealthtechLongevity

Co-investorsAgent CapitalJacket River Capital PartnersOlive Tree CapitalService Provider CapitalFred Hutchinson Cancer Research CenterHumboldt+1 more

Affini-T TherapeuticsinJul 2024

BiotechWatertown, US

Kathy Bergsteinsson(Executive Officer)inKathy Yi(Executive Officer)inJoseph Knowles(Executive Officer, Director)

BoardLucio Iannone(Director)inArjun Goyal(Director)Jill DeSimone(Director)

Co-investorsVida Ventures

Agbiomeagbiome.comSep 2021Acquired

US agricultural biotech that discovered microbe-based crop protection products; its assets were sold to Certis Biologicals and Ginkgo Bioworks in 2024.

AgTechResearch Triangle Park, US

Scott Uknes(Manager)inEric Ward(Manager)Paul Schulze-Lefert(President)Michael Koziel(Vice President and Manager)

BoardThomas Dietz(Manager)Kristina Burow(Manager)in

Co-investorsAliment CapitalBlue Horizon CorporationPontifax AgTechARCH Venture PartnersBill & Melinda Gates FoundationNovalis LifeSciences+1 more

American Autonomyamerican-autonomy.cominSeries A · Oct 2023 · $6M

American Autonomy develops drone software solutions for agricultural equipment manufacturers, including ground control stations, data management systems, and ecosystem integrations to enable farmers to access and utilize drone-collected data for decision-making.

AgTechAI & Machine LearningEnterprise SoftwareHardwareRoboticsSaaSIowa City, US

Mariah Scott(CEO)in

Co-investorsAg Ventures AllianceAgLaunch AcceleratorFulcrum Global Capital

Andesandes.bioMar 2023

Andes is a mission-driven company focused on protecting the planet and applying technology in a nature-related context.

AgTechBiotechClimate Tech

Co-investorsAccelr8Capria VenturesCavallo VenturesGermin8 VenturesSunna VenturesVoyager Partners+3 more

Andes Agandesag.com

Andes develops a microbial technology that converts atmospheric carbon dioxide into stable soil inorganic carbon, enabling agricultural fields to generate verified carbon credits for emissions reductions.

AgTechCleantechClimate TechImpact & Social GoodAlameda, US

Co-investorsCavallo VenturesKdT VenturesVoyager Partners

Apollo Agricultureapolloagriculture.comNov 2019

Apollo Agriculture provides small-scale farmers with farming inputs, financing, insurance, and training to help them run more profitable agribusinesses.

AgTechAI & Machine LearningFintechImpact & Social GoodOakland, US

Earl Joseph St. Sauver(Director)inEli Pollak(Founder)inBenjamin Njenga(Founder)inEarl St Sauver(Founder)in

BoardSeth Todd Silverman(Director)in

Co-investorsAccionAnthemis VentureCeniarthCommunitas Capital PartnersEndeavor CatalystEquator+7 more

BCD BioscienceinDec 2024 · $27M

BiotechDavis, US

Steven Watkins(Executive Officer, Director, Promoter)inCarlito Lebrilla(Director, Promoter)

Co-investorsArgonautic VenturesiSelect FundAcre Venture PartnersCollaborative FundMitsui & CoMorado Ventures+1 more

Bloom Sciencebloomscience.comin𝕏Dec 2021

Bloom Science is a clinical-stage biotech company developing live biotherapeutic products that replicate the effects of the ketogenic diet through the gut-brain axis.

BiotechDeep TechDigital HealthSan Diego, US

Co-investorsALS Investment FundJoyance PartnersPsyMed VenturesSocial StartsApollo Health Ventures

Cavallo Venturescavallovc.cominSep 2021

Cavallo Ventures is the venture capital arm of Wilbur-Ellis, investing in innovative technology companies across agriculture, specialty chemicals, and animal nutrition sectors.

AgTechEnterprise Software

Michael Wilbur(President)in

Co-investorsWilbur-Ellis [Cavallo]Accelr8Builders VCGermin8 VenturesKdT Ventures

Celea Therapeuticsceleatx.cominJul 2026 · $180M

Celea develops deupirfenidone, a pulmonary therapeutic targeting idiopathic pulmonary fibrosis in partnership with physicians and patient advocacy organizations.

BiotechHealthtechMedical Devices

Co-investorsPureTech HealthRA Capital

Cellino Biocellinobio.cominJan 2022

Cellineobio develops cell engineering and bioprocess technology platforms.

AI & Machine LearningBiotechDeep TechMedical DevicesCambridge, US

Nabiha Saklayen, PhD(Co-Founder & CEO)inMarinna Madrid, PhD(Co-Founder & Chief Product Officer)inNabiha Saklayen(Founder)inMatthias Wagner(Founder)inMarinna Madrid(Founder)Stan Wang(Founder)

Co-investors8VCCota CapitalFelicis VenturesHAWKTAILKhosla VenturesThe Engine Ventures+1 more

Cylinder Healthvivantehealth.comin𝕏

Vivante Health is a digital health company focused on gastrointestinal (GI) care, developing data-driven, value-based health programs and technology for managing digestive conditions.

Digital HealthHealthtechWellness & FitnessHouston, US

Kimon Angelides(Founder)inSally Welborn(Director)William Snyder(Executive Officer, Director)Marco Veremis(Director)inShawn Ellis(Director)inSanford Duncan(Director)

Co-investors7wire VenturesCorewell Health VenturesLifeforce CapitalMercato PartnersPeterson VenturesBig Pi Ventures+5 more

Deka Biosciencesdekabiosciences.com

BiotechGermantown, US

John Mumm(Executive Officer, Director)Vera Mumm(Executive Officer)Pavel Khrimian(Executive Officer, Director)Lucio Iannone(Director)Sally (Yuanheng) Wang(Director)

BoardLu Han(Director)in

Co-investorsATEM Capital FundLumira VenturesPlains VenturesEcho Investment CapitalMPM BioImpact

Dewpointdewpointinnov.cominFeb 2022

Dewpoint Innovations develops functional nanostructured polymeric surfaces for atmospheric water capture, technology originating from PhD research at the University of Sydney.

CleantechClimate TechDeep TechNew Materials

Chiara Neto(Founder & Advisor (Chief Scientific Officer))inMing Chiu(Founder & CTO)in

Co-investorsImpact Ventures Management Pty LtdPacific Channel3E Bioventures CapitalARCH Venture PartnersEcoR1 CapitalGeneral Catalyst+3 more

Edifice Healthedificehealth.comin𝕏Series A · Apr 2021 · $12M

Edifice Health offers the Inflammatory Age test, a biomarker composite scoring system that measures and monitors a person's inflammatory and immune health for early detection and prevention of chronic disease.

AI & Machine LearningBiotechDigital HealthHealthtechLongevitySan Mateo, US

David Furman, PhD(Co-Founder & Chairman of the Scientific Advisory Board)Mark Davis, PhD(Co-Founder & Scientific Advisory Board Member)inWolfgang Daum(Executive Officer, Director)inDavid Goldberg(CEO)inDavid Furman(Director)

BoardNaveen Krishnan(Director)in

Co-investorsBetter Food VenturesJoyance PartnersPaladin Capital GroupSocial StartsAhren Innovation CapitalVertical Venture Partners

eGenesisegenesis.comSeries B · Nov 2019 · $100M

Biotechnology company using multiplex gene editing to develop genetically engineered porcine organs for human transplantation.

BiotechBrookline, US

Luhan Yang(President, Secretary and Treasurer)Geoff MacKay(Chief Executive Officer)

BoardGeorge M. Church(Director)

Co-investorsAlta PartnersARCH Venture PartnersCatalio Capital Management, LPHBM Healthcare InvestmentsHBM PartnersKhosla Ventures+12 more

Fork & Goodforkandgood.cominJan 2019

Fork & Good develops cultivated meat technology using a hydroponic system approach that integrates cell biology with farming principles to produce real meat from cells at scale.

BiotechDeep TechFoodTechNutley, US

Gabor Forgacs(Chief Scientific Officer and co-founder)inAndras Forgacs(Partner and co-founder)Niya Sharma(Co-founder)Niyati Gupta(Executive Officer, Director)in

BoardLauren Loktev(Director)

Co-investorsAIR CapitalBBG VenturesCollaborative FundMindshift CapitalThe Venture CollectiveTrue Ventures+1 more

Gandeevagandeeva.comin𝕏Jan 2022 · $40M

Gandeeva Therapeutics uses AI, machine learning, and atomic-resolution cryo-EM imaging to map druggable protein interactions and design molecular glues that bind at specific protein interfaces.

AI & Machine LearningBiotechDeep TechDigital Health

Sriram Subramaniam(Founder)in

Co-investorsAir Street CapitalLux CapitalObvious VenturesAmgen VenturesAmplitude Venture Capital

Huma Therapeuticshuma.comin𝕏May 2021

Huma is a cloud platform that provides regulated AI infrastructure for healthcare and life sciences organizations, enabling them to build AI-driven applications, analytics, and clinical workflows across 70+ countries through a federated network model.

AI & Machine LearningDigital HealthHealthtechLondon, GB

Dan Vahdat(Founder and CEO)in

Co-investorsFuture Positive CapitalHitachi VenturesKickstart InnovationRaptor GroupRho Capital PartnersRho Ventures+5 more

Immunitas Therapeuticsimmunitastx.cominSeries B · Aug 2021 · $58M

Immunitas discovers and develops therapeutic antibodies for cancer and autoimmune diseases, with its lead program targeting CD161 for solid tumors and hematological malignancies.

BiotechDigital HealthMedical DevicesWaltham, US

Amanda Wagner(Executive Officer)Dan Matloff(Executive Officer)Jiaping Gu(Director)Jeffrey Goldberg(Executive Officer, Director)

BoardLaura Brass(Director)inKai Wucherpfennig(Director)

Co-investorsAgent CapitalDC Investment PartnersLifelinkLongwood FundMedical Excellence CapitalNovartis Venture Fund+5 more

Khloris Bioscienceskhlorisbiosciences.comin𝕏Dec 2018

Khloris Biosciences develops iPSC-based cancer vaccines, using induced pluripotent stem cells to trigger a multi-faceted anti-tumor immune response.

BiotechHealthtechLongevitySouth San Francisco, US

Joseph C. Wu(Director)Lynne A. Bui(Co-Founder, President, CEO, and Chairman of the Board)

Leaf Tradeleaf.tradein

Leaf Trade is a B2B marketplace platform connecting cannabis cultivators and dispensaries for wholesale transactions.

AgTechB2B MarketplacesFintechSaaSChicago, US

James Yi(Executive Officer, Director)inMichael Piermont(Executive Officer, Director)Daniel Reich(Director)Jeff Kleban(Director)Woody Benson(Director)

Co-investorsArtemis Growth PartnersGreat Oaks Venture CapitalChingona VenturesHyde Park Angels

MedArrivemedarrive.comNov 2021

MedArrive provides software for scheduling, routing, and real-time tracking of in-home care delivery teams.

HealthtechLogistics & Supply ChainSaaSNew York, US

Inna Plumb(Executive Officer)inDaniel Trigub(Executive Officer, Director)

BoardWilliam Sullivan(Director)Annie Case(Director)inAndy Harrison(Director)Agneta Breitenstein(Director)in

Co-investors7wire VenturesCobalt VenturesCorewell Health VenturesDeclaration PartnersKleiner PerkinsDefine Ventures+2 more

Metagenomimetagenomi.coin𝕏Jan 2022 · $175M

Metagenomi is a genetic medicines company developing therapies based on gene editing technologies to treat patients with serious diseases.

BiotechDeep TechHealthtechMedical DevicesBerkeley, US

Brian Thomas(Founder)inBrian Thomas Jillian Banfield(Founder)Jill Banfield(Founder)Jian Irish(President and CEO)

BoardAndrew Farquharson(Director)inJak Knowles(Director)

Co-investorsCatalio Capital Management, LPRA CapitalSozo VenturesAgent CapitalFrazier Life SciencesHumboldt+5 more

Mozart Therapeuticsmozart-tx.comSeries A · Jun 2023 · $25M

Mozart Therapeutics develops protein therapeutics focused on immunology and oncology treatments.

BiotechMedical Devices

Mark Davis(Scientific Co-Founder)K. Christopher Garcia(Scientific Co-Founder)Calvin Kuo(Scientific Co-Founder)Katie Fanning(President & Chief Executive Officer)in

Co-investorsARCH Venture PartnersJDRF T1D FundMRL Ventures FundOno Venture Investment, Inc.Pfizer Venture InvestmentsSofinnova Partners+6 more

Navanavabenefits.comin𝕏

Nava Benefits is a technology-enabled benefits brokerage that pairs benefits consultants with AI-powered tools to help HR teams manage employee health benefits with less administrative work and lower costs.

HealthtechHR TechInsurTech

Brandon Weber(Founder)inDonald DeSantis(Founder)Kareem Zaki(Founder)

Co-investorsAlumni VenturesArchetypeAvid VenturesGaingelsGlynn Capital ManagementHomebrew+4 more

NewLeaf Symbioticsnewleafsym.comin𝕏

NewLeaf develops PPFM (Pink-Pigmented Facultative Methylotroph) microbial technologies for agriculture, offering EPA-registered biofungicide and bioinsecticide products (TS601 and TS201) plus crop-specific biostimulants for growers of corn, soy, cotton, rice and other crops.

AgTechBiotechSt. Louis, US

Thomas Laurita(Executive Officer, Director)Michael McFatrich(Executive Officer)Desmond Jimenez(Executive Officer)inStephen Kahn(Executive Officer)Janne Kerovuo(Executive Officer)inDoug Bryant(Executive Officer)

Co-investorsAlumni VenturesPangaea Ventures Us Inc.S2G InvestmentsSABIC Ventures

NextPoint Therapeuticsnextpointtx.comin𝕏Feb 2024 · $42.5M

NextPoint is a precision therapeutics company developing cancer treatments targeting the B7-H7/HHLA2 axis, including a T-cell engager, an antibody-drug conjugate with proprietary linker technology, and a multi-functional checkpoint inhibitor.

BiotechHealthtechAustin, US

Gordon Freeman(Scientific Founder)XingXing Zang(Scientific Founder)inIvan Cheung(Chief Executive Officer)inLeena Gandhi(Chief Medical Officer)inTatiana Novobrantseva(Chief Scientific Officer)inAxel Hoos(Director)

Co-investorsCatalio Capital Management, LPMPM BioImpactSanofi VenturesCatalio Capital ManagementInvusSixty Degree Capital

NuCicernucicer.cominSeed · Nov 2022 · $3M

NuCicer develops improved crop varieties through selective breeding, starting with high-protein chickpeas designed for better nutrition.

AgTechAI & Machine LearningFoodTechDavis, US

Kathryn Cook(Executive Officer, Director)inDouglas Cook(Executive Officer, Director)

BoardPaimun Amini(Director)inJerry Steiner(Director)inCarsten Boers(Director)in

Co-investorsBetter Ventures Central LlcBlue Horizon CorporationIllumina VenturesLever VCRhapsody Venture PartnersStray Dog Capital+1 more

Nuvig Therapeuticsnuvigtx.comDec 2024

Nuvig Therapeutics is a biotech company developing immune-modulating therapies for autoimmune and chronic inflammatory diseases, using an endogenous regulatory mechanism intended to treat inflammation without compromising broader immune function.

BiotechLongevity

Co-investorsSanofi Venturesabrdn plcAlexandriaB CapitalDigitalis VenturesGlobal BioAccess Fund+4 more

One Bioone.bioDec 2024

One.bio develops food products designed to provide beneficial molecular signals to support health and address chronic inflammatory disease.

BiotechFoodTechHealthtechWellness & Fitness

Matt Amicucci(Co-Founder & Chief Science Officer)Matt Barnard(Co-Founder & CEO)in

Co-investorsAcre Venture PartnersAlpha EdisonBetter Ventures Central LlcCollaborative FundDoon CapitalE12 Venture Capital, Llc+6 more

Paratus Sciencesparatussciences.cominSeries A · Feb 2023 · $100M

Paratus Sciences is a drug discovery company that uses AI-powered methods to identify first-in-class medicines by studying evolutionary traits, targeting serious diseases where current therapies are inadequate.

AI & Machine LearningBiotechDeep TechUnited States, US

Co-investorsARCH Venture PartnersClavystBioEcoR1 Capital

RantizoinOct 2023 · $6M

Iowa City, US

Matthew Beckwith(Executive Officer, Director)Michael Ott(Executive Officer, Director)

Co-investorsFulcrum Global CapitalInnova Memphis, Inc.

Sabantosabantoag.comSeries B · Jul 2026

Sabanto retrofits existing tractors with an aftermarket autonomy system so growers can run field operations without a driver.

Craig Rupp(Founder)in

Co-investorsCavallo VenturesCerity Partners VenturesDCVC (Data Collective)DCVC BioFulcrum Global CapitalTrimble Ventures+1 more

Sound Agriculturesound-agriculture.cominDec 2022 · $75M

AgTechEmeryville, US

Eric Davidson(Director)inTravis Bayer(Director)inPaul Beck(Executive Officer)inDave Vosburg(Executive Officer)Adam Litle(Executive Officer, Director)inDerek Norman(Director)in

Co-investorsCavallo VenturesCultivian Sandbox VenturesFall Line CapitalS2G InvestmentsFootPrint CoalitionNorthpond Ventures+2 more

Sudo Biosudobio.comFeb 2024

Sudo Biosciences develops small molecule therapeutics for neurological and immune-mediated inflammatory conditions.

BiotechHealthtechMedical DevicesMenlo Park, US

Jim Bristol(Director)Daniel Estes(Director)inScott Byrd(Executive Officer, Director)in

Co-investorsFrazier Life SciencesMonograph Capital PartnersPICUS CAPITALSanofi VenturesSV Health InvestorsDementia Discovery Fund+2 more

Summer Healthsummerhealth.comin𝕏Apr 2024

Summer Health provides text-based, on-demand pediatric care that connects parents with doctors within minutes for their children's non-scheduled health needs.

ConsumerDigital HealthHealthtech

Ellen D.(Founder)inEllen DaSilva(Founder)Matthew Woo(Founder)

Co-investors7wire VenturesCoalition OperatorsCorewell Health VenturesIngeborg InvestmentsLux CapitalSequoia Capital+8 more

Transcarenttranscarent.cominMay 2024 · $126M

Transcarent operates a generative AI-powered health and care platform that combines medical, pharmacy, and point solutions into a single member experience, helping people navigate the healthcare system and access on-demand care.

AI & Machine LearningDigital HealthHealthtechDenver, US

Glen Tullman(Founder)in

Co-investors7wire VenturesAlta PartnersCorewell Health VenturesGeneral CatalystGeodesic CapitalGreatPoint Ventures+9 more

Triumvira Immunologicstriumvira.comin𝕏Aug 2020 · $55M

Triumvira is a clinical-stage immuno-oncology company developing autologous and allogeneic T cell therapeutics for cancer treatment.

BiotechHealthtechMedical DevicesAustin, US

TERESA MCROBERTS(Executive Officer)inPAUL LAMMERS, MD, MSc(Executive Officer, Director)inJON IRVIN(Executive Officer)in

BoardDANIEL JANSE(Director)JURGEN ECKHARDT(Director)ELIZABETH WILLIAMS(Director)

Co-investorsATEM Capital FundB Capital GroupB4 CapitalCheckmate Capital Group LLCNorthpond VenturesOceanpine Capital

Ukkoukko.usinJul 2017

Ukko develops immuno-therapeutics for life-threatening food allergies using a computational protein design platform.

AI & Machine LearningBiotechDigital HealthMountain View, US

Anat Binur(Founder)inYanay Ofran(Founder)inJudith Weiss Paltiel(PhD, VP Development)in

BoardScott Brady(Director)Samir Kaul(Director)in

Co-investorsIsrael Biotech FundKhosla VenturesSanara CapitalWestern Technology InvestmentFall Line CapitalPeakBridge VC

Woebotwoebot.ioin𝕏

Woebot Health builds chat-based AI wellness tools to provide mental health support to individuals and organizations.

AI & Machine LearningDigital HealthMental Health

Alison Darcy(Founder & CEO, PhD)in

Co-investorsJAZZ Venture PartnersOwl VenturesSDVAI FundAlumni VenturesGaingels+3 more

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

BE BiopharmaCaspian Therapeutics

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.